The paradigm that misexpression of IRX3 confers a differentiation block is further supported by our observation that co-expression of IRX3 with Hoxa9 in T-lineage cultures impeded differentiation of ETPs into downstream developmental stages and that IRX3-expressing HSPCs generated lymphoid leukemias in vivo. The gene discussed is IRX3; the disease is lymphoid leukemia.